tiprankstipranks
Company Announcements

vTv Therapeutics CFO Steven Tuch to Resign

Story Highlights
vTv Therapeutics CFO Steven Tuch to Resign

The latest update is out from vTv Therapeutics ( (VTVT) ).

On February 24, 2025, vTv Therapeutics announced that Steven Tuch, its Executive Vice President and Chief Financial Officer, plans to resign effective March 21, 2025. The company is actively seeking a successor through an external search, and Mr. Tuch’s departure is not due to any disagreements with the company or its auditors.

More about vTv Therapeutics

vTv Therapeutics Inc. operates in the pharmaceutical industry, focusing on the development of orally administered small molecule drug candidates to fill unmet medical needs.

YTD Price Performance: 37.36%

Average Trading Volume: 15,466

Technical Sentiment Consensus Rating: Sell

Current Market Cap: $59.45M

For an in-depth examination of VTVT stock, go to TipRanks’ Stock Analysis page.

Questions or Comments about the article? Write to editor@tipranks.com

Questions or Comments about the article? Write to editor@tipranks.com
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App